Wednesday, June 7, 2023
  • Login
CEO North America
  • Home
  • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
    • Environment
  • Opinion
  • News
  • Multimedia
No Result
View All Result
  • Home
  • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
    • Environment
  • Opinion
  • News
  • Multimedia
No Result
View All Result
CEO North America
No Result
View All Result

Moderna sues Pfizer/BioNTech over Covid vaccine technology

in News
Moderna sues pfizer/biontech over covid vaccine technology
Share on LinkedinShare on WhatsApp

Moderna is suing Pfizer and BioNTech for patent infringement in the development of the first U.S. Covid-19 vaccine approved, the company announced Friday.

The Cambridge, Massachusetts firm claims partners Pfizer and BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before Covid-19 emerged late 2019.

“We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the Covid-19 pandemic,” Moderna CEO Stephane Bancel said in the statement.

Moderna had been an innovator in the messenger RNA (mRNA) vaccine technology, which shortens approval processes to months, instead of the years it took to be completed.

The lawsuit was filed in U.S. District Court in Massachusetts and the Regional Court of Dusseldorf in Germany.

The U.S. Food and Drug Administration granted emergency use authorization for the vaccine to both Pfizer/BioNTech and Moderna in consecutive weeks in December 2020.

New York based Pfizer and Mainz, Germany based BioNTech are already facing multiple lawsuits from other companies who say the partnership’s vaccine infringes on their patents.

Moderna has also been sued for patent infringement in the U.S. and has an ongoing dispute with the U.S. National Institutes of Health over rights to mRNA technology.

Tags: BioNTechCOVID vaccineFDAModernaPfizer

Related Posts

Videogame retailer gamestop fires ceo
News

Videogame retailer GameStop fires CEO

Cnn’s ceo chris licht steps down
News

CNN’s CEO Chris Licht steps down

Former coinbase manager, brother settle sec insider-trading charges
News

Coinbase threatens to take SEC fight to US Supreme Court

Reddit to cut workforce by 5%
News

Reddit to cut workforce by 5%

- sequoia capital to separate us, china operations
News

Sequoia Capital to separate US, China operations

Apple curtails specs of self-driving car, delays debut
News

Apple shares hit all-time high amid new product launches

Spotify to cut 6% of workforce
News

Spotify to lay off 200 staff

3m to cut 2,500 jobs
Environment

3M settles $10 billion water pollution claims with US cities

How ergonomics impacts health and safety in the workplace
News

US companies’ hiring surpasses all forecasts, but wage growth slows

Elon musk has an active stake in twitter; started buying stock in january
News

Twitter now worth one-third of Elon Musk’s purchase price

No Result
View All Result

Recent Posts

  • Videogame retailer GameStop fires CEO
  • Apple should buy Disney to harness potential of Vision Pro
  • How wildfire smoke affects human health
  • CNN’s CEO Chris Licht steps down
  • US trade gap widens to largest in six months as exports decline

Recent Comments

    Archives

    Categories

    • Art & Culture
    • Business
    • CEO Interviews
    • CEO Life
    • Editor´s Choice
    • Entrepreneur
    • Environment
    • Food
    • Health
    • Highlights
    • Industry
    • Innovation
    • Issues
    • Management & Leadership
    • Multimedia
    • News
    • Opinion
    • PrimeZone
    • Printed Version
    • Travel
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    • CONTACT
    • GENERAL ENQUIRIES
    • ADVERTISING
    • MEDIA KIT
    • DIRECTORY
    • TERMS AND CONDITIONS

    Editorials – stuart.james@ceo-na.com

    Advertising – media@ceo-na.com

    NEW YORK

    110 Wall St.,
    3rd Floor
    New York, NY.
    10005
    USA
    +1 212 432 5800

     

    MEXICO CITY

    Paseo de la Reforma 296,
    Floor 38
    Mexico City
    06600
    MEXICO

    • CONTACT
    • GENERAL ENQUIRIES
    • ADVERTISING
    • MEDIA KIT
    • DIRECTORY
    • TERMS AND CONDITIONS

    Editorials –
    stuart.james@ceo-na.com

    Editor-In-Chief –

    caroline.sposto@ceo-na.com

    Editorials – editorials@ceo-na.com

    Advertising –
    media@ceo-na.com

    NEW YORK

    110 Wall St.,
    3rd Floor
    New York, NY.
    10005
    USA
    +1 212 432 5800

    MEXICO CITY

    Paseo de la Reforma 296,
    Floor 38
    Mexico City
    06600
    MEXICO

    CEO North America © 2022 - Sitemap

    No Result
    View All Result
    • Home
    • Business
      • Entrepreneur
      • Industry
      • Innovation
      • Management & Leadership
    • CEO Interviews
    • CEO Life
      • Art & Culture
      • Food
      • Health
      • Travel
      • Environment
    • Opinion
    • News
    • Multimedia

    © 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In

    Warning: array_sum() expects parameter 1 to be array, null given in /home/ceonacom/public_html/wp-content/plugins/jnews-social-share/class.jnews-social-background-process.php on line 111